Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, targeted rollout,” one analyst said.
According to a June 26 notice posted to FDA’s website, Edwards Lifesciences has secured 510(k) clearance for its ECLIPTIS Left Atrial Appendage Exclusion System. Edwards Lifesciences enters LAA device ...
CLEVELAND – University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in the world to implant Medtronic’s Penditure™ Left Atrial Appendage (LAA) Exclusion System ...
AtriCure, Inc. ATRC recently announced receipt of regulatory approval from China’s National Medical Products Administration (NMPA) for its AtriClip Left Atrial Appendage (LAA) Exclusion System. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results